SUMMARY: Streptococcus agalactiae (group B Streptococcus, GBS) is the leading cause of neonatal sepsis and meningitis and an important pathogen in elderly patients and those with underlying diseases. The diagnosis of GBS infections is primarily based on culture of GBS. Some clinical laboratories perform the Christie-Atkins-Munch-Peterson (CAMP) test for discrimination of GBS from other streptococci. Here, we developed a rapid GBS identification method, i.e., the loop-mediated isothermal amplification (LAMP) method for detecting the cfb gene encoding the CAMP factor. This method detected at least 4 copies of the cfb gene in GBS under isothermal conditions with in a short time (659 C, within 90 min). No inappropriate amplification of nucleotide by this method was observed when the chromosomal DNA of 17 streptococci and enterococci species, other than GBS, were used as templates. In this investigation, we successfully developed a LAMP method for rapid and highly sensitive detection of GBS, which provides a beneficial alternative to the conventional CAMP test.
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Streptococcus agalactiae (group B Streptococcus, GBS) is the leading cause of neonatal sepsis and meningitis and is responsible for high mortality and morbidity, particularly in invasive infections of neonates (1) (2) (3) (4) (5) (6) (7) (8) ; it is also an important pathogen in elderly patients and those with underlying diseases that impair immunological defense mechanisms against pathogenic microbes. Some cases of neonatal GBS infections are caused by vertical GBS transmission to the neonate during accouchement. Approximately 5z of GBS-infected infants die, and those who survive often develop severe neurological sequelae, such as mental retardation and visual or auditory disabilities (5) .
Vaccination may aid in the prevention of invasive neonatal GBS infections, but there is no approved GBS vaccine currently available (9, 10) . The United States Centers for Disease Control and Prevention (CDC) recommends intrapartum antibiotic prophylaxis (5) . After implementation of this recommendation, the morbidity of early-onset (postnatal week 1) GBS infections has partially decreased.
The CDC recommendations include the culture of GBS from vaginal/rectal specimens of pregnant women to arrive at a diagnosis of GBS colonization. Some clinical laboratories perform the Christie-Atkins-MunchPeterson (CAMP) test to discriminate GBS from other streptococci. The CAMP test detects the CAMP factor, a pore-forming cytotoxin that generates a cohemolytic reaction with Staphylococcus aureus b-toxin; however, it requires 2 consecutive overnight cultures. Therefore, it is important to develop a more rapid, highly sensitive, and specific method to facilitate prompt diagnosis.
The loop-mediated isothermal amplification (LAMP) method (11-13) can amplify target nucleotide sequences at isothermal conditions (usually 609 C-659 C) within 90 min by using 4 or 6 primers. Amplification can be detected by macroscopic observation of turbidity or color change of a fluorescent dye (13) . Furthermore, this method does not require specific or expensive equipment after adjustment of optimal reaction conditions using equipment for real-time turbidity measurement in a reaction tube. Only 2 reports have previously described the development of LAMP for detecting GBS: one that amplified the 16S rRNA gene combined with restriction enzyme digestion of the products, in which multiple time-consuming steps were required (14) and a second that involved detection of fbsB (15); however, this method had limited sensitivity because only 49.5z of GBS strains harbor this gene (16) . Therefore, we attempted to develop a single-step LAMP method for detecting GBS.
To develop the LAMP primers for detecting GBS, we All LAMP reactions were all-or-none. We used a turbidity value of 0.5 as the tentative threshold for a positive test. Fig. 1 . Sensitivity of the LAMP method for detecting GBS. Various amounts (0 g-100 pg) of purified chromosomal DNA of GBS ATCC BAA-611 (2603V/R) were used as templates. The LAMP method was performed at 659 C for 90 min by using the primers listed in Table 1 . Increase in turbidity in the tubes containing 10 fg (estimated 4 copies) and increased amounts of chromosomal DNA were detected.
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targeted the cfb gene that encodes the CAMP factor because it is specific to GBS and harbored by almost all clinical isolates (96.2z) (17) . We designed many candidate primers on the basis of the full-length cfb sequence (gbs2000) of GBS ATCC12403 (NEM316) using Primer Explorer ver. 4 and finally selected 6 LAMP primers ( Table 1 ). The LAMP reactions were performed using a Loopamp } DNA Amplification Kit (Eiken Chemical Co., Tokyo, Japan) and the LA-320C Loopamp } Realtime Turbidity Detector (Eiken Chemical) according to the manufacturer's instructions. DNA specimens were prepared from 15 streptococcal and 3 enterococcal species (Table 2) . Each bacterium was cultured using Todd-Hewitt broth (BD Co., Tokyo, Japan) or brain heart infusion broth (BD). DNA was purified using the Wizard Genomic DNA Purification Kit (Promega KK, Tokyo, Japan). All strains used in the present study were purchased from the American Type Culture Collection (Manassas, Va., USA). Our LAMP method detected a significant increase in the turbidity of samples containing 10 fg (approximately 4 copies) to 100 pg (approximately 4 × 10 4 copies) of the cfb gene of GBS chromosomal DNA within 90 min at 659 C ( Fig. 1) but not in samples containing 0 g-1 fg (approximately 0.4 copies). Using 1 ng of purified chromosomal DNA from each strain (Table 2) , an increase in turbidity was detected exclusively in test tubes containing chromosomal DNA from the 6 GBS strains.
We succeeded in the construction of a LAMP method promising rapid detection of GBS with high sensitivity (approximately 4 copies of the cfb gene per test sample) under isothermal conditions (659 C, within 90 min). In ordinary microbiological testing for detection of GBS in clinical specimens, results are obtained only after minimum of 2 days. Moreover, we recently reported the characteristics of GBS with reduced penicillin suscepti-bility (PRGBS) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) . Before we reported on PRGBS, clinical GBS isolates were considered to be uniformly susceptible to b-lactams. Therefore, these agents were often prescribed without performing susceptibility testing. Although no PRGBS has been identified from neonatal invasive infections and vaginal swab specimens of pregnant women thus far (25) , the possible presence of PRGBS would require drug susceptibility tests that include an overnight incubation step. Therefore, rapid and accurate identification of GBS is crucial, and the LAMP method described here presents a great potential for quick and specific GBS identification.
The proposed LAMP method targeted the cfb gene, which encodes the CAMP factor. Although cfb orthologs are present in Streptococcus uberis and Streptococcus iniae, the maximum sequence identities between these orthologs and the cfb gene of GBS are not very high (73z and 72z, respectively). The CAMP factor is produced by almost all clinical GBS isolates (17) . Moreover, the CAMP test is widely used in routine procedures by clinical laboratories for presumptive GBS identification. Therefore, our LAMP method will provide an alternative method to the CAMP test. However, further research is required to evaluate whether our proposed LAMP method can directly amplify the cfb gene from clinical specimens without colony isolation and chromosomal DNA purification. If our LAMP method can directly amplify cfb from clinical specimens, it should be able to detect GBS more rapidly than the Lancefield antigen immunoassay. Although we aim to assess this in future, we successfully developed a LAMP method for rapid and highly sensitive detection of GBS to provide a beneficial alternative to the conventional CAMP test in this investigation.
